Principal, S.R. One

Ms. Jill Carroll is a Principal of SR One, and she joined SR One in 2011 with a background in biotech partnering and corporate development. Previously, she was Senior Director, Corporate Development at Dynavax Technologies (NASDAQ: DVAX) where she completed multiple pharma partnerships and substantial private and public financings. Jill was formerly a biopharmaceutical industry consultant at Clearview Projects and Mercer Management Consulting. She is a Director at Second Genome, Gotham Therapeutics, Arcellx, and Nkarta. She received her B.S. in Chemistry from Duke University and her M.S. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University.